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Abstract
Trichotillomania (TTM) is a poorly understood disorder with no consensus on aetiology or epidemiology; often overlooked
due to high comorbidity rates. Cross-cultural qualitative research is sparse; therefore, an international qualitative study was
conducted. A generic qualitative approach with thematic analysis was used to explore data from asynchronous email inter-
views. The aim of this article is to report participant experiences of seeking treatment. Using a sample of 20 adults (18–
55 years) from 15 different countries, this article highlights lack of access and unmet healthcare needs signifying an inadequate
supply of TTM expertise globally and the need for more robust clinical guidance.
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Introduction
Trichotillomania (TTM) is a poorly understood disorder (1)
commonly resulting in clinically significant distress and
impairment across all aspects of life, with subsequent hair
loss not attributable to another medical condition or mental
health disorder (2). Secrecy and non-disclosure tendencies
of people with TTM and lack of awareness by healthcare pro-
fessionals (3) all contribute towards diagnostic under-
recognition in the general population. Prevalence was
largely unknown for decades; the first large epidemiological
survey examining prevalence in a USA general population
sample (4) revealed 1.7% of participants as having current
TTM, with the lifetime TTM rate at 2.5%. There is a
dearth of qualitative enquiry around TTM with cross-cultural
research being limited (5).
TTM impacts health and wellbeing in numerous ways;
physical complications including skin infections, bleeding, irri-
tation and inflammation from excessive hair-pulling (3).
Trichophagia (ingesting hair) is associated with risk of tricho-
bezoar (mass of ingested hair) which can prove fatal without
surgical intervention. Functional outcomes associated with
TTM include impairment in social, occupational, academic
and psychological functioning (1). Chronic hair-pullers often
experience depression, anxiety, embarrassment, feelings of
unattractiveness and low self-esteem (6). TTM is known to
be a distressing disorder commonly linked to secrecy and
shame; a lack of understanding about the availability and effi-
cacy of interventions further contributes toward poor prognosis
and routine outcomes (7). Little is known about the experience
of people living with TTM from a qualitative perspective and
despite several reviews (3,7), little is known about the cause,
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epidemiology or aetiology of TTM, with treatment yielding
mixed results at best (3). This article reports participant
access to and experiences of seeking treatment for TTM.
Method
A generic qualitative approach was utilised (8). Data origi-
nated from an international sample and comprised in-depth
asynchronous email interviews. Ethical approval was
granted by a university research ethics panel. Participants
provided informed consent, were notified of their rights to
anonymity, confidentiality and rights of withdrawal from
the study. Participants were debriefed and provided with
support measures at the end of participation. A purposive
sampling strategy was utilised to specifically recruit individ-
uals with a common experience of having TTM.
Semi-structured asynchronous email interviews (9) were
flexible and took place over 8–10 email exchanges.
Inclusion criteria contained screening questions guided by
the DSM-5 criteria for TTM (2). Exclusion criteria included
a screening question which aimed to identify anyone who
considered themself to be at risk. Within the international
sample, the ability to speak and write in English was not a
pre-defined criterion; the general message seeking partici-
pants was written in English and only participants who
could respond in English volunteered their participation.
Data were analysed using the six-phase thematic analysis
process by Braun and Clarke (10); a method that is largely
independent of theory and offers a flexible process of analy-
sing data. The thematic analysis was developed inductively
to locate semantic level themes, aiming to facilitate data
driven findings. Nested within a larger study, participants
were asked questions related to their experiences of seeking
treatment for TTM.
Results
During 2016, email interviews were conducted with 20 partic-
ipants (13 female) from 15 countries; mean age 34.3 years; age
range 18–55 years; reported onset of TTM range was 5–26
years; TTM had been experienced for an average of 20.05
years. Sample demographics are noted in Table 1. Four
people dropped out of the interview citing various reasons
(e.g. change of mind, time constraints) and six people began
the interview but stopped responding; dropout and non-
responder data were not used. Thematic analysis highlighted
one theme; lapse in duty of care, and one sub-theme; inade-
quate training of healthcare professionals.
Lapse in Duty of Care
Most participants reported unmet needs in relation to support,
referral, or treatment options for their TTM:
‘My doctor cant [can’t] even say the word ‘trichotillomania’
he offered no help and he is unwilling to even read about it’
(P10 – Female, 32, Mauritius)
Some participants described instances where healthcare
professionals failed to offer any treatment and seemed to
place the responsibility of stopping hair-pulling behaviours
directly onto the participant:
‘I have not tried any treatment because no treatments have
been offered to me by doctors. They have just said I should
control it myself’ (P6 – Male, 30, Brazil)
This seemed to resonate with other participants who sug-
gested they were told to ‘just live’ with TTM, resulting in
some participants feeling alone in their diagnosis:
‘I have tried no treatment, no treatment was offered! I was
told it is incurable and I should just live with the problem.
I am alone in this battle with Trichotillomania and there is
no help’ (P7 – Female, 22, China)
Inadequate Training of Healthcare Professionals
Participants described their difficulties in dealing with health-
care professionals; all 20 participants expressed that many
primary healthcare providers had a lack of training around
TTM:
‘My mum took me to see 4 doctors (2 GP’s, 1 Dermatologist,
and 1 Psychiatrist). The first 3 knew nothing about Trich
[Trichotillomania], would tell my mum I’d grow out of it
and I should just stop (…) It was frustrating (…) 3 out of 4
were not educated enough to diagnose Trichotillomania….
That’s 75%. Just ludicrous’ (P9 – Male, 26, Australia)
Coupled with the perception that healthcare providers lack
understanding and adequate training when facing a patient
with TTM, participants experienced significant delays in
receiving a formal diagnosis:
‘I have been pulling for 12 years there about, but I was only
diagnosed 2 years ago (…) doctors don’t understand that it’s
a real problem. 3 GP’s did not diagnose me, the diagnosis
was made with psychiatrist’ (P4 – Male, 29, India)
There were expressions of frustration at the lack of under-
standing healthcare professionals have about TTM, with
claims of knowing ‘bare essential’ information about the
disorder:
‘In a total of 30 years trying to seek help, and only ONE
person knew the bare essential information about
Trichotillomania. (…) most times when I tell a healthcare
‘‘professional’’ I have Trichotillomania, they will say
something such as ‘you can just stop if you try hard
enough’ (P3 – Male, 54, Germany)
Participant experiences suggest a lack of sensitivity train-
ing among healthcare professionals; this ranged from general
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misunderstanding of the disorder, perceptions of repulsion
and descriptions of how healthcare professionals ‘gave up’
too easily:
‘I don’t feel they ever quite understood. They gave up on me
too easily, or tried to push drugs at me. With some, I even got
a sense that they were repulsed by it’ (P1 – Female, 49,
Massachusetts)
Participants expressed frustration at attempting to seek
help for TTM but not being taken seriously, with suggestions
that some healthcare professionals do not perceive TTM to be
a life impacting disorder:
‘I have been pulling on & off for 26 years now and was only
diagnosed about 8 years ago. My doctor has been very hes-
itant to try me on any medicine, he doesn’t think the tricho-
tillomania causes much of a distruption [disruption] in my
life. I have asked for help, and he says it should be manage-
able without medicine…talk about frustrating! Sometimes
doctors don’t know best.’ (P17 – Male, 52, Cape Town)
There were other descriptions detailing minimal clinician
effort alongside the assumption that TTM is not viewed as a
serious enough disorder; this may subconsciously affect the
level at which clinicians provide support:
‘He didn’t offer me help, and he has never made any effort to
read up about treatments for me. That is the most frustrating
thing… they are not willing to learn about it to try and help
because in their view it’s not an important or serious condi-
tion’ (P10 – Female, 32, Mauritius)
Discussion
TTM impairment appears to worsen over time; mild to moder-
ate social and interpersonal impairment is evident in childhood
(11) which often progresses to moderate to severe impairment
in later life (1). Participants’ accounts of their unmet healthcare
needs suggest early intervention may impact positively on
health and social outcomes. Often the first point of contact,
GP’s face a formidable challenge when dealing with patients
who have complex symptoms (12) of disorders with no
known aetiology. People with TTM may benefit from
improved access to psychological therapies, especially those
with chronic symptoms as they often experience comorbidity
and make heavy demand on multiple healthcare services,
with generally unsatisfactory outcomes (13). TTM symptoms
may often exacerbate comorbid disorders and vice versa;
there is a tendency within specialist services to keep things sep-
arated, this can result in people with comorbidity falling
through the cracks (14) and signals a need for partnership
across healthcare departments.
Treatment seeking behaviours are low within the TTM
population; in one study, just over 61% of survey participants
sought treatment, but only 14.8% reported a moderate to
large reduction in TTM symptoms (1). Current findings
suggest treatment seeking commonly results in unmet health-
care needs; this finding can be used to inform how clinicians
better understand and support people with TTM. Previous
research (3,15) highlighted an inadequate supply of health-
care providers trained to treat TTM and called for more infor-
mation and training to address the global shortage of therapist
expertise. Unfortunately, based on the current findings, this
has remained the same a decade later. Participant accounts
of perceived repulsion on the part of the clinicians suggests
professional support could in some cases be adversely influ-
enced by clinicians’ personal feelings about TTM; relevant
training for clinicians could therefore include an examination
of conscious and unconscious bias. To compare current find-
ings, future research may investigate healthcare professional
perceptions and experiences of supporting patients with
TTM. Previous research noted low clinician ratings of
impairment for TTM patients (16); this contradicts accumu-
lating evidence which highlights the negative consequences
associated with TTM and further emphasises that TTM is a
misunderstood disorder.
As comorbidity is common with TTM, clinical services
should aim to utilise an inclusive approach whereby provi-
sions should be needs-led rather than service-led (14).
Arguably, study findings emphasise the importance of
patient-centred support that offers an appropriate response
Table 1. Demographic Information of the Asynchronous Email Interview Sample.
Participant Gender Location Age Reported age of onset Participant Gender Location Age Reported age of onset
P1 Female Massachusetts 49 10 P11 Female Abu Dhabi 24 9
P2 Female New Zealand 44 12 P12 Male Johannesburg 35 20
P3 Male Germany 54 24 P13 Female Jamaica 18 14
P4 Male India 29 17 P14 Female Ireland 28 5
P5 Male Canada 46 5 P15 Female Switzerland 55 25
P6 Male Brazil 30 12 P16 Female Illinois 42 24
P7 Female China 22 10 P17 Male Cape Town 52 26
P8 Female Morocco 20 7 P18 Female England 31 13
P9 Male Australia 26 16 P19 Female Ohio 27 16
P10 Female Mauritius 32 9 P20 Female Wales 22 11
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to people with TTM experiencing distress. Further, coupled
with the need for TTM training in the healthcare field,
there should be a move toward development and pilot of a
novel, accessible specialist service for people with TTM.
The asynchronous email interview method provided an
acceptable and feasible way to access an international
sample of people with TTM, while eliminating the need to
travel. Long-term email engagement facilitated rapport. The
method was effective in highlighting participants’ shared
experience of misunderstandings on the part of clinicians,
delayed diagnosis and difficulty accessing appropriate TTM
treatment.
Limitations
Interviews that take longer to complete may result in a higher
possibility of dropouts (17). Given the sample size; it was not
a specific aim to produce generalisable findings. Despite
reported limitations of internet recruitment, internet sampling
procedures can provide results consistent with traditional
methods (18). Limited clinical and demographic information
was gathered, though the inclusion of screening questions
guided by the DSM-5 criteria for TTM () (2) may have mit-
igated the absence of verified participant diagnoses.
Conclusion
TTM remains a misunderstood disorder with poor prognosis.
The wide-ranging impairments and comorbidities associated
with TTM imply high societal costs, highlighting a need for
greater knowledge and understanding of the condition. Many
people with TTM are underserved and have unmet healthcare
needs; guidance for practitioners on this subject is generally
sparse, changes to policy and practice are warranted and pro-
vision of education for clinicians is needed. These findings
can inform how clinicians support people with TTM and
suggest avenues for further research.
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